All In Biotech

Free tool

FAERS Monitor: Carnitor Sf

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 019257 or its brand name (Carnitor Sf, Levocarnitine). Reports on generic versions are filed under their own applications.

Reports

3,681

Serious

2,842

77% of reports

Hospitalization

1,730

Death reported

401

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • seizure400
  • off label use310
  • vomiting232
  • diarrhoea211
  • drug ineffective196
  • fatigue188
  • pneumonia185
  • pyrexia175
  • product dose omission issue136
  • nausea135
  • somnolence132
  • decreased appetite123
  • death122
  • dyspnoea107
  • headache92

Reports by year received

View as table
YearReports
200423
200517
200612
200728
200853
200932
201030
201134
201257
201372
201483
2015124
2016228
2017160
2018197
2019238
2020272
2021258
2022362
2023412
2024410
2025356
2026223

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,050,478 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
seizureSignal40019.918.17,157
somnolenceSignal1323.73.2266
pneumoniaSignal1853.32.8293
decreased appetiteSignal1233.02.5167
pyrexiaSignal1752.92.5218
vomitingSignal2322.82.5277
product dose omission issueSignal1362.62.2139
off label useSignal3102.01.8166
diarrhoea2111.91.687
fatigue1881.41.220
dyspnoea1071.10.91
nausea1351.00.80
drug ineffective1960.80.75
headache920.80.73
death1220.80.76

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.